Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan J Darrow

Showing results (21-30 of 82) with videos related to

Pageof 9
Sort By:
The New England Journal of Medicine|April 12, 2018
The FDA Breakthrough-Drug Designation - Four Years of ExperienceJonathan J Darrow, Jerry Avorn, Aaron S Kesselheim
The New England Journal of Medicine|March 28, 2014
New FDA breakthrough-drug category--implications for patientsJonathan J Darrow, Jerry Avorn, Aaron S Kesselheim
The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics|October 4, 2013
Institutional corruption of pharmaceuticals and the myth of safe and effective drugsDonald W Light, Joel Lexchin, Jonathan J Darrow
The New England Journal of Medicine|July 3, 2014
New FDA breakthrough-drug category--implications for patientsJonathan J Darrow, Jerry Avorn, Aaron S Kesselheim
JAMA|August 3, 2021
FDA Regulation and Approval of Medical Devices: 1976-2020Jonathan J Darrow, Jerry Avorn, Aaron S Kesselheim
The New England Journal of Medicine|April 9, 2015
Expanded access to investigational drugsAmeet Sarpatwari, Jonathan J Darrow, Aaron S Kesselheim
Nature Biotechnology|January 4, 2019
An export-only exception to pharmaceutical patents in Europe: should the United States follow suit?Timo Minssen, Aaron S Kesselheim, Jonathan J Darrow
The New England Journal of Medicine|December 7, 2017
Speed, Safety, and Industry Funding - From PDUFA I to PDUFA VIJonathan J Darrow, Jerry Avorn, Aaron S Kesselheim
The American Surgeon|December 21, 2020
Evidence Supporting the Value of Surgical Procedures: Can We Do Better?Jonathan J Darrow, Christopher T Robertson, Willard S Kasoff
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|December 4, 2018
A Method for Approximating Future Entry of Generic DrugsReed F Beall, Jonathan J Darrow, Aaron S Kesselheim
Pageof 9

Showing results (21-30 of 82) with videos related to

Sort By:
Pageof 9
The New England Journal of Medicine|April 12, 2018
The FDA Breakthrough-Drug Designation - Four Years of ExperienceJonathan J Darrow, Jerry Avorn, Aaron S Kesselheim
The New England Journal of Medicine|March 28, 2014
New FDA breakthrough-drug category--implications for patientsJonathan J Darrow, Jerry Avorn, Aaron S Kesselheim
The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics|October 4, 2013
Institutional corruption of pharmaceuticals and the myth of safe and effective drugsDonald W Light, Joel Lexchin, Jonathan J Darrow
The New England Journal of Medicine|July 3, 2014
New FDA breakthrough-drug category--implications for patientsJonathan J Darrow, Jerry Avorn, Aaron S Kesselheim
JAMA|August 3, 2021
FDA Regulation and Approval of Medical Devices: 1976-2020Jonathan J Darrow, Jerry Avorn, Aaron S Kesselheim
The New England Journal of Medicine|April 9, 2015
Expanded access to investigational drugsAmeet Sarpatwari, Jonathan J Darrow, Aaron S Kesselheim
Nature Biotechnology|January 4, 2019
An export-only exception to pharmaceutical patents in Europe: should the United States follow suit?Timo Minssen, Aaron S Kesselheim, Jonathan J Darrow
The New England Journal of Medicine|December 7, 2017
Speed, Safety, and Industry Funding - From PDUFA I to PDUFA VIJonathan J Darrow, Jerry Avorn, Aaron S Kesselheim
The American Surgeon|December 21, 2020
Evidence Supporting the Value of Surgical Procedures: Can We Do Better?Jonathan J Darrow, Christopher T Robertson, Willard S Kasoff
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|December 4, 2018
A Method for Approximating Future Entry of Generic DrugsReed F Beall, Jonathan J Darrow, Aaron S Kesselheim
Pageof 9